Evidence map›Paper›PMID 35545567›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Liver fibrosis inhibits lethal injury through D-galactosamine/lipopolysaccharide-induced necroptosis].

L Li, L Bai, Y Zheng, Z P Chen, Zhongping Duan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

L LiDepartment of Infectious Diseases, Peking University Third Hospital, Beijing 100191, China.
L BaiBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research; The Fourth Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Y ZhengThe First Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Z P ChenBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research; The Fourth Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Zhongping DuanBeijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research; The Fourth Department of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Peking University · CN

Funding

Beijing Advanced Innovation Center for Big Data-Based Precision Medicine PXM2021_014226_000026Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support ZYLX202125Beijing Municipal Natural Science Foundation 7202068, 72222093, 7222094Capital's Funds for Health Improvement and Research 2021-1G-2181National Key R&D Program of China 2017YFA0103000the Digestive Medical Coordinated Development Center of Beijing Municipal Administration of Hospitals XXZ0503
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemical and Drug Induced Liver InjuryLiver Failure, AcuteAnimalsGalactosamineLipopolysaccharidesLiverLiver CirrhosisMiceNecroptosisGalactosamineLipopolysaccharides

Identifiers

PMID35545567
PMCPMC12770635
OpenAlexW4280565861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.